Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Oxford, UK : Blackwell Publishing Ltd
    Forest pathology 27 (1997), S. 0 
    ISSN: 1439-0329
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Agriculture, Forestry, Horticulture, Fishery, Domestic Science, Nutrition
    Notes: After introductory competition tests in the laboratory, Resinicium bicolor was used as a potential control agent for the conifer root rot fungus Heterobasidion annosum. Greenhouse pathogenicity tests with R. bicolor on 4-year-old seedlings of Norway spruce (Picea abies) and Scots pine (Pinus sylvestris) showed moderate incidence of infection. In three places in Sweden, four test areas were chosen for field experiments in first-rotation plantations and also in old forest sites of Norway spruce. Wood blocks, pre-inoculated with one strain of R. bicolor, were buried in the soil beside stumps at 0, 1, 2, 3 and 4 months after thinning using various spatial designs. In two of the test areas, half of the stumps were treated with a suspension of H. annosum conidia from one strain by surface spraying. After 2–3 years, stump roots were investigated and the length of growth of both species were noted. The identity of mycelia reisolated from and wood debris in the test areas were confirmed by somatic compatibility tests with the original strains. The strain of R. bicolor released was recovered from all over the test area; the released H. annosum strain was only reisolated from the conidia sprayed stump roots. R. bicolor had little effect on the growth and occurrence of H. annosum. Potential control of disease spread may arise, however, from occlusion of the pathogen from outer parts of roots.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1569-8041
    Keywords: chemotheapy ; dose escalation ; efficacy ; Hodgkin's disease ; toxicity
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract The BEACOPP chemotherapy regimen for advanced Hodgkin's disease employs a rearranged schedule permitting a shortened three-week cycle. With haematological growth factor support, the dosages of cyclophosphamide, etoposide and adriamycin could be moderately escalated. The 3-armed multicentre HD9 trial (recruitment 1993-1998; 1300 patients randomised) aimed to compare BEACOPP with the standard COPP/ABVD chemotherapy and to detect and measure the gain in efficacy, if any, due to moderate dose escalation of BEACOPP. Eight cycles were given, followed by local irradiation. The most recent interim analysis, with 689 evaluable patients, circa 40% of all expected events and a median observation time of 27 months, showed significant differences in progression rate (P) and in two-year freedom from treatment failure (F) between the treatment arms, with escalated BEACOPP (P = 2%, F = 89%) better than baseline BEACOPP (P = 9%, F = 81%) better than COPP/ABVD (P = 13%, F = 72%). Survival was not significantly different. Acute toxicity was more severe due to dose escalation, but remained manageable. These preliminary results suggest that BEACOPP improves efficacy. Moderate dose escalation is feasible with G-CSF support and appears likely to make a worthwhile improvement in the cure rate. The results must await confirmation (or otherwise) by the final analysis including all randomised patients and sufficiently mature data.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...